Bipolar Disorder CME: MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder: The France Foundation: Minneapolis, MN: October 2, 2008
- By MEASURE by The France Foundation
- Published 09/12/2008
- Psychiatry
- Unrated
MEASURE - From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder
MEASURE by The France Foundation
Now in it's sixth year, the objective of MEASURE is to provide psychiatrists and health care providers with a comprehensive continuing medical education program that will examine emerging clinical advances while addressing educational issues critical to improving the management of serious psychiatric disorders, including bipolar disorder.
View All Postings by This Contributor.
Location:
McCormick & Schmick's Seafood Restaurant
Minneapolis, MN
Course Directors/Instructors:
David E. Adson, MD
Course Fee:
Free
Number of Credits:
1 AMA PRA Category 1
Link
Detailed Description:
The goal of the MEASURE Dinner Meetings is to provide psychiatrists with an interactive continuing medical education activity that addresses ongoing complex issues with the diagnosis and treatment of patients with bipolar disorder. Expert bipolar faculty deliver a lecture entitled "From Neurobiology to Pharmacotherapy: Advances in Our Understanding of Bipolar Disorder" followed by a question/answer session.
For More Information
Call Toll Free: 1-866-856-1998 Fax: 1-860-434-5390
Learning Objectives:
- Describe neurophysiological findings and neurocognitive deficits in bipolar disorder and various phases of the illness
- Discuss how individual factors such as age, the presence of comorbidities, or ethnic/cultural issues impact the diagnosis and treatment of bipolar disorder
- Interpret emerging data from studies on bipolar disorder therapy
- Determine the appropriate strategies for multimodal combination therapies in the acute and long-term management of bipolar disorder
Spread The Word
Comments
No Comments Found.This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.
CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.



